AASLD The Liver Meeting

Whether you're a clinician, surgeon, researcher, trainee, advocate, academic, or policymaker — AASLD is where the global hepatology community comes together. With access to the latest breakthroughs in liver disease research, practical tools for patient care, and a powerful network of experts shaping the future of hepatology, the program offers something for everyone committed to improving liver health. 

That’s why Ipsos is delighted to be showcasing insights from our MASH Therapy Monitor at the event.

Weight management is pivotal in MASH treatment, but where does it fit in physicians' clinical assessments? Ipsos’ Ayse Levent will present a poster exploring this critical question with our latest data insights on November 8, 2025 [The Importance of Weight Reduction in MASH Management].

To join us, please visit the AASLD website.

Speaker:

• Ayse Levent, SVP, Global Therapy Monitors